Hebei Changshan Biochem Pharma (300255) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.021x

Based on the latest financial reports, Hebei Changshan Biochem Pharma (300255) has a cash flow conversion efficiency ratio of -0.021x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-30.86 Million ≈ $-4.52 Million USD) by net assets (CN¥1.48 Billion ≈ $216.35 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Hebei Changshan Biochem Pharma for the company's overall valuation and market capitalisation.

Hebei Changshan Biochem Pharma - Cash Flow Conversion Efficiency Trend (2008–2024)

This chart illustrates how Hebei Changshan Biochem Pharma's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Hebei Changshan Biochem Pharma Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hebei Changshan Biochem Pharma ranked by their cash flow conversion efficiency. Explore cash flow quality index of Hebei Changshan Biochem Pharma to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Sigma Advanced Systems Limited NSE:MEGASOFT	-0.777x
MeiHua Holdings Group Co Ltd SHG:600873	0.150x
Dhc Software Co Ltd SHE:002065	0.047x
Vita Coco Company Inc NASDAQ:COCO	0.202x
Shanghai Phichem Material Co Ltd Class A SHE:300398	0.030x
GRAIL, LLC NASDAQ:GRAL	-0.032x
SUNRISE N SW:SUNN	-0.006x
Baoding Heavy Industry Co Ltd SHE:002552	0.122x

Annual Cash Flow Conversion Efficiency for Hebei Changshan Biochem Pharma (2008–2024)

The table below shows the annual cash flow conversion efficiency of Hebei Changshan Biochem Pharma from 2008 to 2024. View Hebei Changshan Biochem Pharma stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥1.54 Billion ≈ $224.73 Million	CN¥56.22 Million ≈ $8.23 Million	0.037x	+95.34%
2023-12-31	CN¥1.80 Billion ≈ $263.35 Million	CN¥33.73 Million ≈ $4.94 Million	0.019x	+1731.13%
2022-12-31	CN¥3.05 Billion ≈ $446.90 Million	CN¥3.13 Million ≈ $457.36K	0.001x	+9.49%
2021-12-31	CN¥3.07 Billion ≈ $449.55 Million	CN¥2.87 Million ≈ $420.19K	0.001x	+101.45%
2020-12-31	CN¥2.85 Billion ≈ $417.52 Million	CN¥-183.58 Million ≈ $-26.86 Million	-0.064x	-201.33%
2019-12-31	CN¥2.72 Billion ≈ $398.35 Million	CN¥-58.13 Million ≈ $-8.51 Million	-0.021x	-118.40%
2018-12-31	CN¥2.52 Billion ≈ $369.20 Million	CN¥292.81 Million ≈ $42.85 Million	0.116x	+74.17%
2017-12-31	CN¥2.44 Billion ≈ $356.37 Million	CN¥162.28 Million ≈ $23.75 Million	0.067x	-11.29%
2016-12-31	CN¥2.29 Billion ≈ $335.01 Million	CN¥171.96 Million ≈ $25.16 Million	0.075x	+409.43%
2015-12-31	CN¥1.57 Billion ≈ $229.92 Million	CN¥-38.14 Million ≈ $-5.58 Million	-0.024x	+59.24%
2014-12-31	CN¥1.43 Billion ≈ $208.80 Million	CN¥-84.97 Million ≈ $-12.43 Million	-0.060x	-402.15%
2013-12-31	CN¥1.29 Billion ≈ $188.11 Million	CN¥-15.24 Million ≈ $-2.23 Million	-0.012x	+81.10%
2012-12-31	CN¥1.13 Billion ≈ $164.72 Million	CN¥-70.62 Million ≈ $-10.33 Million	-0.063x	-463.52%
2011-12-31	CN¥987.45 Million ≈ $144.49 Million	CN¥17.04 Million ≈ $2.49 Million	0.017x	-87.05%
2010-12-31	CN¥219.39 Million ≈ $32.10 Million	CN¥29.25 Million ≈ $4.28 Million	0.133x	-12.34%
2009-12-31	CN¥159.19 Million ≈ $23.30 Million	CN¥24.21 Million ≈ $3.54 Million	0.152x	+146.09%
2008-12-31	CN¥93.43 Million ≈ $13.67 Million	CN¥-30.83 Million ≈ $-4.51 Million	-0.330x	--

About Hebei Changshan Biochem Pharma

SHE:300255 China Biotechnology

Market Cap

$3.08 Billion

CN¥21.05 Billion CNY

Market Cap Rank

#4842 Global

#798 in China

Share Price

CN¥22.90

Change (1 day)

+0.57%

52-Week Range

CN¥21.95 - CN¥69.80

All Time High

CN¥69.80